Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag crawled date : 2021 - 09 - 23 save search
Global $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements
Published: 2021-09-23 (Crawled : 12:00) - prnewswire.com
NVS | News | $98.17 3.21% 780K
|
Health Technology
|
| O: 0.92%
H: 0.5%
C: 0.01%
BMY | $49.28 0.29% 800K
|
Health Technology
|
| O: 0.42%
H: 1.55%
C: 0.38%
VCEL | $46.025 1.42% 9K
|
Health Technology
|
| O: 0.86%
H: 2.12%
C: 1.89%
QURE | $4.84 0.42% 34K
|
Health Technology
|
| O: 0.5%
H: 0.58%
C: -5.62%
BLUE | $1.01 5.91% 790K
|
Health Technology
|
| O: 1.11%
H: 2.8%
C: 2.53%
BIIB | $194.76 0.34% 110K
|
Health Technology
|
| O: 1.51%
H: 2.09%
C: -0.17%
therapy approval
Biosimilars Market by Application and Geography | Global Forecast to 2025 | 17,000+ Technavio Research Reports
Published: 2021-09-22 (Crawled : 00:00) - prnewswire.com
VTRS | News A | $11.3 0.44% 570K
|
Health Technology
|
| O: 0.38%
H: 1.5%
C: 0.3%
NVS | News | $98.17 3.21% 780K
|
Health Technology
|
| O: 0.92%
H: 0.5%
C: 0.01%
BIIB | $194.76 0.34% 110K
|
Health Technology
|
| O: 1.51%
H: 2.09%
C: -0.17%
AMGN | News | $272.245 0.12% 220K
|
Health Technology
|
| O: -0.53%
H: 1.43%
C: 1.2%
research application biosimilar
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M
|
AGBA | $2.46 96.8% 28M
|
Finance
EDBL | News | $6.94 84.57% 1.4M
|
CZOO | $7.74 55.11% 2.7M
|
PALI | $7.64 54.97% 14M
|
Manufacturing
OPRT | News | $3.19 41.78% 3M
|
Finance
PEGY | $0.0629 37.34% 110M
|
Manufacturing
ZAPP | $6.02 35.59% 95K
|
n/a
MLEC | $1.87 33.57% 1.6M
|
n/a
VNRX | $0.759 26.5% 390K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.